by admin | Jul 28, 2022 | Breast cancer
Ribociclib and letrozole Tablets FDA expands ribociclib indication in HR-positive, HER2-negative advanced or metastatic breast cancer. On July 18, 2018, the Food and Drug Administration expanded the indication for ribociclib (Kisqali, Novartis Pharmaceuticals...
by admin | Jul 18, 2022 | eye
aflibercept Injection On 27 August 2014, Eylea was also indicated for the treatment of people with visual impairment due to diabetic macular oedema, according to the updated summary of product characteristics. In May 2019 FDA expanded the indication for aflibercept to...
by admin | Jul 18, 2022 | Dermatology
dupilumab injection FDA Approves First Treatment for Eosinophilic Esophagitis, a Chronic Immune Disorder. Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years. Are...
by admin | Jul 18, 2022 | Dermatology
apremilast tablets Apremilast is indicated in the United States for the treatment of adults with active psoriatic arthritis, adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy, and adults with oral ulcers associated with...
by admin | Jul 18, 2022 | Respiratory Disorders
budesonide and formoterol fumarate dihydrate Inhalation Aerosol FDA Approves First Generic of Symbicort to Treat Asthma and COPD. Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate)...
